These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 11709455)
1. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Peene I; Meheus L; Veys EM; De Keyser F Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455 [TBL] [Abstract][Full Text] [Related]
2. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario. Sebastian W; Roy A; Kini U; Mullick S Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497 [TBL] [Abstract][Full Text] [Related]
3. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population. Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344 [TBL] [Abstract][Full Text] [Related]
4. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing. Tipu HN; Bashir MM J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190 [TBL] [Abstract][Full Text] [Related]
5. Detection and identification of antinuclear antibodies (ANA) in a large community hospital. Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Desplat-Jego S; Bardin N; Larida B; Sanmarco M Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550 [TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166 [TBL] [Abstract][Full Text] [Related]
9. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay. Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884 [TBL] [Abstract][Full Text] [Related]
10. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens. Jaskowski TD; Schroder C; Martins TB; Mouritsen L; Hill HR J Clin Lab Anal; 1995; 9(3):166-72. PubMed ID: 7602423 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies. Peene I; Van Ael W; Vandenbossche M; Vervaet T; Veys E; De Keyser F Clin Rheumatol; 2000; 19(4):291-5. PubMed ID: 10941811 [TBL] [Abstract][Full Text] [Related]
12. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study]. Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670 [TBL] [Abstract][Full Text] [Related]
13. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Hoffman IE; Peene I; Veys EM; De Keyser F Clin Chem; 2002 Dec; 48(12):2171-6. PubMed ID: 12446473 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey. Sener AG; Afsar I; Demirci M APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay. Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430 [TBL] [Abstract][Full Text] [Related]
16. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies. Van Praet JT; Vander Cruyssen B; Bonroy C; Smith V; Delanghe J; De Keyser F Clin Exp Rheumatol; 2009; 27(6):971-6. PubMed ID: 20149314 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies]. Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906 [TBL] [Abstract][Full Text] [Related]
18. From ANA to ENA: how to proceed? Damoiseaux JG; Tervaert JW Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206 [TBL] [Abstract][Full Text] [Related]
19. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078 [TBL] [Abstract][Full Text] [Related]
20. Detection of antinuclear antibodies (ANA), antibodies to double stranded DNA (anti-dsDNA) and antibodies to extractable nuclear antigens (anti-ENA) in Greek patients. Stamouli M; Skliris A; Reppa D; Maganaki E; Totos G Clin Lab; 2013; 59(3-4):283-91. PubMed ID: 23724616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]